Coherus Biosciences | Passifs Courants





Passifs Courants Changement Date
AbbVie USD 39.39B 376M 2025-09
Acadia Pharmaceuticals USD 356.58M 26.56M 2025-09
Akebia Therapeutics USD 133.38M 14.66M 2025-09
ALKERMES USD 474.36M 31.6M 2025-09
Alnylam Pharmaceuticals USD 1.56B 254.63M 2025-09
Amarin USD 182.23M 3.71M 2025-09
Amgen USD 25.49B 3.7B 2025-12
Baxter International USD 3.78B 836M 2025-09
Biogen USD 3.35B 59.4M 2025-12
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Coherus Biosciences USD 372.3M 108.67M 2025-09
Eli Lilly USD 40.14B 1.12B 2025-09
Fujifilm JPY 1.2T 44.21B 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
Ironwood Pharmaceuticals USD 242.5M 9.98M 2025-09
Merck USD 28.63B 2.59B 2025-09
Myriad Genetics USD 148M 51.9M 2025-09
Pacira USD 107.08M 206.09M 2025-09
Perrigo USD 1.15B 19.2M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
PTC Therapeutics USD 866.24M 238.44M 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Sarepta Therapeutics USD 921.42M 1.48M 2025-09
Teva Pharmaceutical Industries USD 13.46B 1.96B 2025-12
Vertex Pharmaceuticals USD 4.48B 336.9M 2025-09
Xencor USD 86.48M 9.6M 2025-09
Zoetis USD 1.81B 1.56B 2025-09


Coherus Biosciences Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.